Through its technology appraisal programme, the National Institute for Health and Care Excellence (NICE) provides independent, evidence-based guidance for the National Health Service on whether drugs and treatments represent a clinically and cost effective use of NHS resources. NICE is appraising Brentuximab for this indication and recently consulted stakeholders on its draft recommendations. Brentuximab is currently available to NHS patients with relapsed and refractory Hodgkin lymphoma through the Cancer Drugs Fund.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"} } , "answeringMemberConstituency" : {"_value" : "Oxford West and Abingdon"} , "answeringMemberPrinted" : {"_value" : "Nicola Blackwood"} , "dateOfAnswer" : {"_value" : "2017-02-15", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-02-15T13:39:18.99Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-02-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Brentuximab Vedotin"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps his Department is taking to ensure relapsed and refractory Hodgkin lymphoma patients continue to have access to brentuximab vedotin.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "63498"} , {"_about" : "http://data.parliament.uk/resources/678626", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/678626/answer", "answerText" : {"_value" : "
The National Health Service is a national, not an international, service. This Government was the first to introduce tough measures to clamp down on migrants accessing free NHS care, including introducing the immigration health surcharge.<\/p>
<\/p>
The initiatives we have implemented have meant the income identified from visitors and migrants has trebled from £89 million in 2012/13 to £289 million in 2015/16.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1542", "label" : {"_value" : "Biography information for Philip Dunne"} } , "answeringMemberConstituency" : {"_value" : "Ludlow"} , "answeringMemberPrinted" : {"_value" : "Mr Philip Dunne"} , "dateOfAnswer" : {"_value" : "2017-02-02", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-02-02T13:35:40.177Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-01-25", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health Services: Foreign Nationals"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what recent progress his Department has made on recovering money from overseas visitors and other chargeable NHS patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "61532"} , {"_about" : "http://data.parliament.uk/resources/671782", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/671782/answer", "answerText" : {"_value" : "
The £200 million fund NHS England announced in December 2016 will be available to Cancer Alliances over the next two years to specifically support the areas the Cancer Taskforce strategy estimated would need additional investment including implementing the Recovery Package and rolling out stratified follow up pathways.<\/p>
<\/p>
Initial bids for funding are due on 18 January 2017. Clear guidance has been published and a regional and national panel will assess all bids received. The funding will be signed off by the NHS England Investment Committee.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4080", "label" : {"_value" : "Biography information for David Mowat"} } , "answeringMemberConstituency" : {"_value" : "Warrington South"} , "answeringMemberPrinted" : {"_value" : "David Mowat"} , "dateOfAnswer" : {"_value" : "2017-01-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-01-19T11:56:42.413Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-01-11", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cancer: Health Services"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, with reference to NHS England's announcement on 6 December 2016 of an additional £200 million to improve local cancer services, what plans he has to ensure that that money will be used to roll out the Recovery Package and stratified pathways of follow-up care as costed in the Independent Cancer Taskforce report.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "59671"} , {"_about" : "http://data.parliament.uk/resources/528906", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/528906/answer", "answerText" : {"_value" : "
It is important that people with cancer have the best possible experience throughout their cancer pathway and are treated with dignity and respect.<\/p>
<\/p>
The independent Cancer Taskforce published its report Achieving World-Class Cancer Outcomes \u2013 A Strategy for England 2015-2020<\/em> in July 2015, and identified a key priority of establishing patient experience as being on a par with clinical effectiveness and safety. In May 2016 the National Cancer Transformation Board published Achieving World-Class Cancer Outcomes:<\/em> Taking the Strategy Forward<\/em> outlining the detailed steps being taken to make this a reality.<\/p> <\/p> In September 2015, the Government announced that by 2020, the 280,000 people diagnosed with cancer every year will benefit from a tailored recovery package. The packages will be individually designed to help each person, including those with blood cancer, live well beyond cancer. In April 2016 NHS England published guidance for commissioners on commissioning and implementing the recovery package effectively.<\/p> <\/p> In order to continue to support general practitioners (GPs) to identify patients whose symptoms may indicate cancer and urgently refer them as appropriate, the National Institute for Health and Care Excellence (NICE) published an updated suspected cancer referral guideline in June 2015. The guideline includes new recommendations for haematological cancers. NICE noted that more lives could be saved each year in England if GPs followed the new guideline, which encourages GPs to think of cancer sooner and lower the referral threshold. Following publication of the updated guideline, the Royal College of GPs (RCGP) has worked in collaboration with Cancer Research UK (CRUK) on a programme of regional update events for GPs to promote the new guideline. RCGP and CRUK have also worked to develop three summary referral guidelines for GPs to enable them to adopt the guideline. These are available at:<\/p> <\/p> www.cancerresearchuk.org/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2016-07-05", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "41285"}
, {"_value" : "41329"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-07-05T15:11:22.383Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-06-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Blood Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the implications for his policies of the findings of the National Cancer Patient Experience Survey 2015 on the proportion of blood cancer patients who visited their GP more than twice before being referred to secondary care for diagnosis; and what support and guidance his Department has provided to GPs to enable them to identify the symptoms of blood cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"}
}
, "tablingMemberConstituency" : {"_value" : "Crawley"}
, "tablingMemberPrinted" : [{"_value" : "Henry Smith"}
], "uin" : "41284"}
, {"_about" : "http://data.parliament.uk/resources/528907", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/528907/answer", "answerText" : {"_value" : " Public Health England\u2019s (PHE) Be Clear on Cancer campaigns are designed to raise the public\u2019s awareness of specific cancer symptoms, encourage people with those symptoms to go to the doctor and diagnose cancer at an earlier stage. These campaigns are delivered by PHE in partnership with the Department and NHS England.<\/p> <\/p> The decision on which cancers should be the focus of \u2018Be Clear on Cancer\u2019 campaigns is informed by a steering group, whose members include primary and secondary care clinicians, and key voluntary sector organisations.<\/p> <\/p> A number of factors are taken into account when deciding which campaigns to develop and run, with one of the main criteria being the scope to save lives through earlier diagnosis and whether the cancer has a clear early sign or symptom that the general public can act upon should it arise. There are a number of cancers, including those for which symptoms can be non-specific, which are not covered by \u2018Be Clear on Cancer\u2019 specifically.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2016-07-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-07-05T15:10:26.383Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-06-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer: Health Education"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps his Department is taking to raise public awareness of blood cancer and other cancers for which symptoms can be non-specific and have similarities to other benign conditions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"}
}
, "tablingMemberConstituency" : {"_value" : "Crawley"}
, "tablingMemberPrinted" : [{"_value" : "Henry Smith"}
], "uin" : "41283"}
, {"_about" : "http://data.parliament.uk/resources/528908", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/528908/answer", "answerText" : {"_value" : " It is important that people with cancer have the best possible experience throughout their cancer pathway and are treated with dignity and respect.<\/p> <\/p> The independent Cancer Taskforce published its report Achieving World-Class Cancer Outcomes \u2013 A Strategy for England 2015-2020<\/em> in July 2015, and identified a key priority of establishing patient experience as being on a par with clinical effectiveness and safety. In May 2016 the National Cancer Transformation Board published Achieving World-Class Cancer Outcomes:<\/em> Taking the Strategy Forward<\/em> outlining the detailed steps being taken to make this a reality.<\/p> <\/p> In September 2015, the Government announced that by 2020, the 280,000 people diagnosed with cancer every year will benefit from a tailored recovery package. The packages will be individually designed to help each person, including those with blood cancer, live well beyond cancer. In April 2016 NHS England published guidance for commissioners on commissioning and implementing the recovery package effectively.<\/p> <\/p> In order to continue to support general practitioners (GPs) to identify patients whose symptoms may indicate cancer and urgently refer them as appropriate, the National Institute for Health and Care Excellence (NICE) published an updated suspected cancer referral guideline in June 2015. The guideline includes new recommendations for haematological cancers. NICE noted that more lives could be saved each year in England if GPs followed the new guideline, which encourages GPs to think of cancer sooner and lower the referral threshold. Following publication of the updated guideline, the Royal College of GPs (RCGP) has worked in collaboration with Cancer Research UK (CRUK) on a programme of regional update events for GPs to promote the new guideline. RCGP and CRUK have also worked to develop three summary referral guidelines for GPs to enable them to adopt the guideline. These are available at:<\/p> <\/p>